We do not bill insurance or accept HSA/FSA funds
Your provider will review your health history, current medications, and weight loss goals
On a molecular level, AOD-9604 is compact enough to achieve good solubility in aqueous diluents yet large enough to retain the structural motif needed for its adipocyte-targeting activity
Beginning July 1 and running through the end of 2027, a new pilot program will allow some Medicare Part D prescription plan members who want to shed excess pounds and maintain weight loss to get Wegovy injections and tablets, Foundayo tablets or the Zepbound KwikPen for a $50 monthly copay
third-party sellers can list a brand's products without the brand's direct involvement
Key Takeaways Two biotech companies, Akston Biosciences and OKAVA Pharmaceuticals, are running early trials of once-weekly injections and a six-month implant GLP-1 treatment to tackle feline obesity, with no approved Ozempic for pets on the market yet